Breaking News

Why there’s a fight brewing over decaf coffee

March 28, 2024
Molly Ferguson for STAT

Covid's scientific silver lining: A chance to watch the human immune system respond in real time

The pandemic offered the first-ever opportunity for scientists to study how the immune system responds to a new threat, in real time, in the global population.

By Helen Branswell


Does decaf coffee contain a harmful additive? Advocates want to ban a certain chemical in the brew

Methylene chloride, used to remove caffeine, virtually undetectable in brewed coffee. Clean Label Project still wants it banned under FDA Delaney Clause.

By Nicholas Florko


Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds

Drugs like Ozempic were linked to a low, but greater risk of aspiration pneumonia following endoscopies, a new study found.

By Elaine Chen



Adobe

STAT+ | Why the world's most expensive drug might not be all that overpriced

In a country with runaway drug spending, gene therapies live on an island of rationality: They cost a fortune but the benefit is priceless.

By Jason Mast


Who can sue the FDA? Answering Justice Alito's question from the mifepristone arguments

Justice Samuel Alito had a question at the arguments over mifepristone: If the doctors who brought that case can't sue the FDA over a drug's label, who can?

By Sarah Owermohle


STAT+ | Payments by drug and device makers to doctors remain widespread, but also vary considerably

"But not all physicians participate in this," said Andrew Foy, co-author of a new study and an associate professor of medicine at Penn State.

By Ed Silverman


Oprah Winfrey speaking earlier this month during the 55th NAACP Image Awards in Los Angeles.
Paras Griffin/Getty Images for BET

Opinion: Oprah kicked off a national conversation on obesity and GLP-1 drugs. Let's have it

On national TV, Oprah endorsed the use of GLP-1 drugs like Wegovy and Ozempic for obesity. She didn't present the whole picture.

By Lisa Shah


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments